Chemopreventive effects of bovine lactoferrin (bLF), previously shown to st
rongly inhibit intestinal carcinogenesis in rats (K. Sekine, E. Watanabe, J
. Nakamura, N. Takasuka, D.J. Kim, M. Asamoto, V. Krutovskikh, T.H. Baba, T
. Ota, M.A. Moore, M. Masuda, H. Sugimoto, H. Nishino, T. Kakizoe, H. Tsuda
, Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin ad
ministration in F344 rats, Jpn. J. Cancer Res. 88 (1997) 523-526; K. Sekine
, Y. Ushida, T. Kuhara, M. Iigo, H. Baba-Toriyama, M.A. Moore, M. Murakoshi
, Y. Satomi, Il. Nishino, T. Kakizoe, I-I. Tsuda, Inhibition of initiation
and early stage development of aberrant crypt foci and enhanced natural kil
ler activity in male rats administered bovine lactoferrin concomitantly wit
h azoxymethane, Cancer Lett. 121 (1997) 211-216), on spontaneous intestinal
polyp development were assessed in the Ape(Min) mouse, a model for both fa
milial adenomatous polyposis and sporadic colon cancers. In the experiment,
54 mice at 6 weeks of age were given 2% bLF (15 mice), 0.2% bLF (15 mice)
and AIN-93G (24 mice) as basal diet ad libitum for 8 weeks. An overall tend
ency for a reduction in the total number of polyps in the small intestine w
as evident in the bLF-treated animals, along with significant suppression i
n the jejunum at the 2% dose (P < 0.05, 68% of the control). In addition, b
ody growth suppression, presumed to be due to anemia and/or intussusception
as a consequence of numerous polyps in the intestine, was alleviated. No t
oxic effects were observed in the intestinal epithelium. Although not as ob
vious as observed for the rat case, the data suggest that bLF may be a chem
opreventor of intestinal polyposis. (C) 1998 Elsevier Science Ireland Ltd.
All rights reserved.